Xeris Biopharma Holdings, Inc. XERS Change in Prepaids
Change in Prepaids at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s change in prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s change in prepaids?
- Xeris Biopharma Holdings, Inc. (XERS) reported change in prepaids of -$145K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s change in prepaids changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s change in prepaids increased by 90.5% year-over-year, from -$1.53M to -$145K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s change in prepaids?
- Over 2 years (2021 to 2023), Xeris Biopharma Holdings, Inc.'s change in prepaids has grown at a -1.3% compound annual growth rate (CAGR), from -$3.29M to -$3.21M.
- What does change in prepaids mean?
- This measures the net change in cash outflows for goods or services paid for in advance of their consumption or recognition as an expense. A significant increase may indicate higher future operational commitments or changes in procurement timing. It is a key component in reconciling net income to operating cash flow.